Livforsakringsbolaget Skandia Omsesidigt Grows Stock Holdings in Colgate-Palmolive (NYSE:CL)

Livforsakringsbolaget Skandia Omsesidigt raised its stake in Colgate-Palmolive (NYSE:CLFree Report) by 37.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,946 shares of the company’s stock after buying an additional 527 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Colgate-Palmolive were worth $155,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in the stock. OFI Invest Asset Management purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $25,000. Avion Wealth lifted its position in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $34,000. Quarry LP lifted its position in shares of Colgate-Palmolive by 48.2% in the 2nd quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after purchasing an additional 145 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research note on Monday, January 29th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price objective for the company. Barclays boosted their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, April 12th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. Finally, Morgan Stanley upped their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

View Our Latest Report on CL

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jennifer Daniels sold 61,633 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock worth $19,505,099 in the last 90 days. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $86.70 on Friday. The company’s 50 day simple moving average is $87.02 and its 200-day simple moving average is $80.67. The company has a market capitalization of $71.27 billion, a price-to-earnings ratio of 31.19, a price-to-earnings-growth ratio of 3.26 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $90.37. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the previous year, the business posted $0.77 EPS. The firm’s revenue was up 6.9% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio is 69.06%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.